Biological and therapeutic relevance of nonreplicative DNA polymerases to cancer

Antioxidants and Redox Signaling

Volumn 18, Issue 8, 2013, Pages 851-873

  Parsons, Jason L ^a   Nicolay, Nils H ^a,b   Sharma, Ricky A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOTRIENOL; BETULIC ACID; BIOLOGICAL MARKER; BLEOMYCIN; CARBOPLATIN; CHLORMETHINE; CISPLATIN; CYTARABINE; CYTOTOXIC AGENT; DNA DIRECTED DNA POLYMERASE BETA; DNA DIRECTED DNA POLYMERASE ETA; DNA POLYMERASE; DNA POLYMERASE IOTA; DNA POLYMERASE KAPPA; DNA POLYMERASE LAMBDA; DNA POLYMERASE MU; DNA POLYMERASE THETA; DNA POLYMERASE ZETA; ETOPOSIDE; GEMCITABINE; MELPHALAN; MESYLIC ACID METHYL ESTER; METHYLFUNICONE; NONREPLICATIVE DNA POLYMERASE; OLEANOLIC ACID; OXALIPLATIN; PLATINUM DERIVATIVE; STIGMASTEROL; TEMOZOLOMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CANCER CELL; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; DNA ADDUCT; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; DNA REPLICATION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IONIZING RADIATION; NONHUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; DNA REPAIR; DNA-DIRECTED DNA POLYMERASE; HUMANS; NEOPLASMS;

EID: 84873866621     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4203     Document Type: Review

References (274)

1. Abdulovic AL and Jinks-Robertson S. The in vivo characterization of translesion synthesis across UV-induced lesions in Saccharomyces cerevisiae: insights into Pol zeta-and Pol eta-dependent frameshift mutagenesis. Genetics 172: 1487-1498, 2006.
2. Acharya N, Johnson RE, Prakash S, and Prakash L. Complex formation with Rev1 enhances the proficiency of Sac-charomyces cerevisiae DNA polymerase zeta for mismatch extension and for extension opposite from DNA lesions. Mol Cell Biol 26: 9555-9563, 2006.
3. Acharya N, Yoon JH, Gali H, Unk I, Haracska L, Johnson RE, Hurwitz J, Prakash L, and Prakash S. Roles of PCNA-binding and ubiquitin-binding domains in human DNA polymerase eta in translesion DNA synthesis. Proc Natl Acad Sci USA 105: 17724-17729, 2008.
4. Adachi M, Ijichi K, Hasegawa Y, Ogawa T, Nakamura H, Yasui Y, Fukushima M, and Ishizaki K. Hypersensitivity to cisplatin after hRev3 mRNA knockdown in head and neck squamous cell carcinoma cells. Mol Med Report 1: 695-698, 2008.
5. Albertella MR, Green CM, Lehmann AR, and O'Connor MJ. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage. Cancer Res 65: 9799-9806, 2005.
6. Albertella MR, Lau A, and O'Connor MJ. The over-expression of specialized DNA polymerases in cancer. DNA Repair (Amst) 4: 583-593, 2005.
7. Allinson SL, Dianova, II, and Dianov GL. DNA polymerase beta is the major dRP lyase involved in repair of oxidative base lesions in DNA by mammalian cell extracts. EMBO J 20: 6919-6926, 2001.
8. Alt A, Lammens K, Chiocchini C, Lammens A, Pieck JC, Kuch D, Hopfner KP, and Carell T. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta. Science 318: 967-970, 2007.
9. Andersen PL, Xu F, and Xiao W. Eukaryotic DNA damage tolerance and translesion synthesis through covalent modifications of PCNA. Cell Res 18: 162-173, 2008.
10. Andreassen PR, Ho GP, and D'Andrea AD. DNA damage responses and their many interactions with the replication fork. Carcinogenesis 27: 883-892, 2006.
11. Aoufouchi S, Flatter E, Dahan A, Faili A, Bertocci B, Storck S, Delbos F, Cocea L, Gupta N, Weill JC, and Reynaud CA. Two novel human and mouse DNA polymerases of the polX family. Nucleic Acids Res 28: 3684-3693, 2000.
12. Arana ME, Seki M, Wood RD, Rogozin IB, and Kunkel TA. Low-fidelity DNA synthesis by human DNA polymerase theta. Nucleic Acids Res 36: 3847-3856, 2008.
13. Asagoshi K, Liu Y, Masaoka A, Lan L, Prasad R, Horton JK, Brown AR, Wang XH, Bdour HM, Sobol RW, Taylor JS, Yasui A, and Wilson SH. DNA polymerase beta-dependent long patch base excision repair in living cells. DNA Repair (Amst) 9: 109-119, 2010.
14. Baker TA and Bell SP. Polymerases and the replisome: machines within machines. Cell 92: 295-305, 1998.
15. Bassett E, Vaisman A, Havener JM, Masutani C, Hanaoka F, and Chaney SG. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin ad-ducts by human DNA polymerases beta and eta in vitro. Biochemistry 42: 14197-14206, 2003.
16. Bavoux C, Leopoldino AM, Bergoglio V, J OW, Ogi T, Bieth A, Judde JG, Pena SD, Poupon MF, Helleday T, Tagawa M, Machado C, Hoffmann JS, and Cazaux C. Up-regulation of the error-prone DNA polymerase {kappa} promotes pleio-tropic genetic alterations and tumorigenesis. Cancer Res 65: 325-330, 2005.
17. Beard WA, Shock DD, Batra VK, Pedersen LC, and Wilson SH. DNA polymerase beta substrate specificity: side chain modulation of the "A-rule". J Biol Chem 284: 31680-31689, 2009.
18. Beard WA, Shock DD, Yang XP, DeLauder SF, and Wilson SH. Loss of DNA polymerase beta stacking interactions with templating purines, but not pyrimidines, alters catalytic efficiency and fidelity. J Biol Chem 277: 8235-8242, 2002.
19. Beard WA and Wilson SH. Purification and domain-mapping of mammalian DNA polymerase beta. Methods Enzymol 262: 98-107, 1995.
20. Beard WA and Wilson SH. Structure and mechanism of DNA polymerase beta. Chem Rev 106: 361-382, 2006.
21. Bebenek K, Garcia-Diaz M, Zhou RZ, Povirk LF, and Kunkel TA. Loop 1 modulates the fidelity of DNA poly-merase lambda. Nucleic Acids Res 38: 5419-5431, 2010.
22. Belousova EA, Maga G, Fan Y, Kubareva EA, Romanova EA, Lebedeva NA, Oretskaya TS, and Lavrik OI. DNA polymerases beta and lambda bypass thymine glycol in gapped DNA structures. Biochemistry 49: 4695-4704, 2010.
23. Bennett SE, Sung JS, and Mosbaugh DW. Fidelity of uracil-initiated base excision DNA repair in DNA polymerase beta-proficient and-deficient mouse embryonic fibroblast cell extracts. J Biol Chem 276: 42588-42600, 2001.
24. Bergoglio V, Ferrari E, Hubscher U, Cazaux C, and Hoffmann JS. DNA polymerase beta can incorporate ribonu-cleotides during DNA synthesis of undamaged and CPD-damaged DNA. J Mol Biol 331: 1017-1023, 2003.
25. Bertocci B, De Smet A, Berek C, Weill JC, and Reynaud CA. Immunoglobulin kappa light chain gene rearrangement is impaired in mice deficient for DNA polymerase mu. Immunity 19: 203-211, 2003.
26. Bertocci B, De Smet A, Weill JC, and Reynaud CA. Nonoverlapping functions of DNA polymerases mu, lambda, and terminal deoxynucleotidyltransferase during immunoglobulin V(D)J recombination in vivo. Immunity 25: 31-41, 2006.
27. Bienko M, Green CM, Sabbioneda S, Crosetto N, Matic I, Hibbert RG, Begovic T, Niimi A, Mann M, Lehmann AR, and Dikic I. Regulation of translesion synthesis DNA polymerase eta by monoubiquitination. Mol Cell 37: 396-407, 2010.
28. Biertumpfel C, Zhao Y, Kondo Y, Ramon-Maiques S, Gregory M, Lee JY, Masutani C, Lehmann AR, Hanaoka F, and Yang W. Structure and mechanism of human DNA poly-merase eta. Nature 465: 1044-1048, 2010.
29. Blanca G, Villani G, Shevelev I, Ramadan K, Spadari S, Hubscher U, and Maga G. Human DNA polymerases lambda and beta show different efficiencies of translesion DNA synthesis past abasic sites and alternative mechanisms for frameshift generation. Biochemistry 43: 11605-11615, 2004.
30. Boudsocq F, Benaim P, Canitrot Y, Knibiehler M, Ausseil F, Capp JP, Bieth A, Long C, David B, Shevelev I, Frierich-Heinecken E, Hubscher U, Amalric F, Massiot G, Hoffmann JS, and Cazaux C. Modulation of cellular response to cis-platin by a novel inhibitor of DNA polymerase beta. Mol Pharmacol 67: 1485-1492, 2005.
31. Braithwaite EK, Kedar PS, Stumpo DJ, Bertocci B, Freed-man JH, Samson LD, and Wilson SH. DNA polymerases beta and lambda mediate overlapping and independent roles in base excision repair in mouse embryonic fibro-blasts. PLoS One 5: e12229, 2010.
32. Branzei D, Seki M, and Enomoto T. Rad18/Rad5/Mms2-mediated polyubiquitination of PCNA is implicated in replication completion during replication stress. Genes Cells 9: 1031-1042, 2004.
33. Brieba LG. Template dependent human DNA polymerases. Curr Top Med Chem 8: 1312-1326, 2008.
34. Brondello JM, Pillaire MJ, Rodriguez C, Gourraud PA, Selves J, Cazaux C, and Piette J. Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta. Oncogene 27: 6093-6101, 2008.
35. Broughton BC, Cordonnier A, Kleijer WJ, Jaspers NG, Fawcett H, Raams A, Garritsen VH, Stary A, Avril MF, Boudsocq F, Masutani C, Hanaoka F, Fuchs RP, Sarasin A, and Lehmann AR. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci USA 99: 815-820, 2002.
36. Brown JA, Pack LR, Sanman LE, and Suo Z. Efficiency and fidelity of human DNA polymerases lambda and beta during gap-filling DNA synthesis. DNA Repair (Amst) 10: 24-33, 2011.
37. Brown JA, Pack LR, Sherrer SM, Kshetry AK, Newmister SA, Fowler JD, Taylor JS, and Suo Z. Identification of critical residues for the tight binding of both correct and incorrect nucleotides to human DNA polymerase lambda. J Mol Biol 403: 505-515, 2010.
38. Brown S, Niimi A, and Lehmann AR. Ubiquitination and deubiquitination of PCNA in response to stalling of the replication fork. Cell Cycle 8: 689-692, 2009.
39. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, and Helleday T. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434: 913-917, 2005.
40. Burgers PM, Koonin EV, Bruford E, Blanco L, Burtis KC, Christman MF, Copeland WC, Friedberg EC, Hanaoka F, Hinkle DC, Lawrence CW, Nakanishi M, Ohmori H, Pra-kash L, Prakash S, Reynaud CA, Sugino A, Todo T, Wang Z, Weill JC, and Woodgate R. Eukaryotic DNA polymer-ases: proposal for a revised nomenclature. J Biol Chem 276: 43487-43490, 2001.
41. Burschowsky D, Rudolf F, Rabut G, Herrmann T, Peter M, and Wider G. Structural analysis of the conserved ubiqui-tin-binding motifs (UBMs) of the translesion polymerase iota in complex with ubiquitin. J Biol Chem 286: 1364-1373, 2011.
42. Cabelof DC, Guo Z, Raffoul JJ, Sobol RW, Wilson SH, Richardson A, and Heydari AR. Base excision repair deficiency caused by polymerase beta haploinsufficiency: accelerated DNA damage and increased mutational response to carcinogens. Cancer Res 63: 5799-5807, 2003.
43. Cabelof DC, Ikeno Y, Nyska A, Busuttil RA, Anyangwe N, Vijg J, Matherly LH, Tucker JD, Wilson SH, Richardson A, and Heydari AR. Haploinsufficiency in DNA polymerase beta increases cancer risk with age and alters mortality rate. Cancer Res 66: 7460-7465, 2006.
44. Canitrot Y, Cazaux C, Frechet M, Bouayadi K, Lesca C, Salles B, and Hoffmann JS. Overexpression of DNA poly-merase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc Natl Acad Sci USA 95: 12586-12590, 1998.
45. Canitrot Y, Frechet M, Servant L, Cazaux C, and Hoffmann JS. Overexpression of DNA polymerase beta: a genomic instability enhancer process. FASEB J 13: 1107-1111, 1999.
46. Canitrot Y, Hoffmann JS, Calsou P, Hayakawa H, Salles B, and Cazaux C. Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: a potential source of genetic instability in cancer cells. FASEB J 14: 1765-1774, 2000.
47. Capp JP, Boudsocq F, Bergoglio V, Trouche D, Cazaux C, Blanco L, Hoffmann JS, and Canitrot Y. The R438W polymorphism of human DNA polymerase lambda triggers cellular sensitivity to camptothecin by compromising the homologous recombination repair pathway. Carcinogenesis 31: 1742-1747, 2010.
48. Capp JP, Boudsocq F, Bertrand P, Laroche-Clary A, Pour-quier P, Lopez BS, Cazaux C, Hoffmann JS, and Canitrot Y. The DNA polymerase lambda is required for the repair of non-compatible DNA double strand breaks by NHEJ in mammalian cells. Nucleic Acids Res 34: 2998-3007, 2006.
49. Capp JP, Boudsocq F, Besnard AG, Lopez BS, Cazaux C, Hoffmann JS, and Canitrot Y. Involvement of DNA poly-merase mu in the repair of a specific subset of DNA double-strand breaks in mammalian cells. Nucleic Acids Res 35: 3551-3560, 2007.
50. Ceppi P, Novello S, Cambieri A, Longo M, Monica V, Lo Iacono M, Giaj-Levra M, Saviozzi S, Volante M, Papotti M, and Scagliotti G. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 15: 1039-1045, 2009.
51. Chan K, Houlbrook S, Zhang QM, Harrison M, Hickson ID, and Dianov GL. Overexpression of DNA polymerase beta results in an increased rate of frameshift mutations during base excision repair. Mutagenesis 22: 183-188, 2007.
52. Chan SH, Yu AM, and McVey M. Dual roles for DNA polymerase theta in alternative end-joining repair of double-strand breaks in Drosophila. PLoS Genet 6: e1001005, 2010.
53. Chaney SG, Campbell SL, Bassett E, and Wu Y. Recognition and processing of cisplatin-and oxaliplatin-DNA adducts. Crit Rev Oncol Hematol 53: 3-11, 2005.
54. Chayot R, Danckaert A, Montagne B, and Ricchetti M. Lack of DNA polymerase mu affects the kinetics of DNA double-strand break repair and impacts on cellular senescence. DNA Repair (Amst) 9: 1187-1199, 2010.
55. Chen J, Bozza W, and Zhuang Z. Ubiquitination of PCNA and its essential role in eukaryotic translesion synthesis. Cell Biochem Biophys 60: 47-60, 2011.
56. Chen KH, Yakes FM, Srivastava DK, Singhal RK, Sobol RW, Horton JK, Van Houten B, and Wilson SH. Up-regu-lation of base excision repair correlates with enhanced protection against a DNA damaging agent in mouse cell lines. Nucleic Acids Res 26: 2001-2007, 1998.
57. Chen YW, Cleaver JE, Hanaoka F, Chang CF, and Chou KM. A novel role of DNA polymerase eta in modulating cellular sensitivity to chemotherapeutic agents. Mol Cancer Res 4: 257-265, 2006.
58. Choi JY, Chowdhury G, Zang H, Angel KC, Vu CC, Peterson LA, and Guengerich FP. Translesion synthesis across O6-alkylguanine DNA adducts by recombinant human DNA polymerases. J Biol Chem 281: 38244-38256, 2006.
59. Choi JY, Lim S, Eoff RL, and Guengerich FP. Kinetic analysis of base-pairing preference for nucleotide incorporation opposite template pyrimidines by human DNA polymerase iota. J Mol Biol 389: 264-274, 2009.
60. Choi JY, Zang H, Angel KC, Kozekov ID, Goodenough AK, Rizzo CJ, and Guengerich FP. Translesion synthesis across 1, N2-ethenoguanine by human DNA polymerases. Chem Res Toxicol 19: 879-886, 2006.
61. Clairmont CA and Sweasy JB. The Pol beta-14 dominant negative rat DNA polymerase beta mutator mutant commits errors during the gap-filling step of base excision repair in Saccharomyces cerevisiae. J Bacteriol 180: 2292-2297, 1998.
62. Covo S, Blanco L, and Livneh Z. Lesion bypass by human DNA polymerase mu reveals a template-dependent, sequence-independent nucleotidyl transferase activity. J Biol Chem 279: 859-865, 2004.
63. Daube SS, Arad G, and Livneh Z. Translesion replication by DNA polymerase beta is modulated by sequence context and stimulated by fork-like flap structures in DNA. Biochemistry 39: 397-405, 2000.
64. DeRose EF, Clarkson MW, Gilmore SA, Galban CJ, Tri-pathy A, Havener JM, Mueller GA, Ramsden DA, London RE, and Lee AL. Solution structure of polymerase mu's BRCT Domain reveals an element essential for its role in nonhomologous end joining. Biochemistry 46: 12100-12110, 2007.
65. Di Lucca J, Guedj M, Lacapere JJ, Fargnoli MC, Bourillon A, Dieude P, Dupin N, Wolkenstein P, Aegerter P, Saiag P, Descamps V, Lebbe C, Basset-Seguin N, Peris K, Grand-champ B, and Soufir N. Variants of the xeroderma pig-mentosum variant gene (POLH) are associated with melanoma risk. Eur J Cancer 45: 3228-3236, 2009.
66. Dianov GL and Parsons JL. Co-ordination of DNA single strand break repair. DNA Repair (Amst) 6: 454-460, 2007.
67. Dianova, II, Sleeth KM, Allinson SL, Parsons JL, Breslin C, Caldecott KW, and Dianov GL. XRCC1-DNA polymerase beta interaction is required for efficient base excision repair. Nucleic Acids Res 32: 2550-2555, 2004.
68. Diaz M, Watson NB, Turkington G, Verkoczy LK, Klinman NR, and McGregor WG. Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt gene of mouse fibroblasts expressing antisense RNA to DNA polymerase zeta. Mol Cancer Res 1: 836-847, 2003.
69. Doles J, Oliver TG, Cameron ER, Hsu G, Jacks T, Walker GC, and Hemann MT. Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy. Proc Natl Acad Sci USA 107: 20786-20791, 2010.
70. Doublie S, Sawaya MR, and Ellenberger T. An open and closed case for all polymerases. Structure 7: R31-R35, 1999.
71. Dumstorf CA, Clark AB, Lin Q, Kissling GE, Yuan T, Ku-cherlapati R, McGregor WG, and Kunkel TA. Participation of mouse DNA polymerase iota in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer. Proc Natl Acad Sci USA 103: 18083-18088, 2006.
72. Dyrkheeva NS, Lomzov AA, Pyshnyi DV, Khodyreva SN, and Lavrik OI. Efficiency of exonucleolytic action of apurinic/apyrimidinic endonuclease 1 towards matched and mismatched dNMP at the 3¢ terminus of different oligomeric DNA structures correlates with thermal stability of DNA duplexes. Biochim Biophys Acta 1764: 699-706, 2006.
73. Efrati E, Tocco G, Eritja R, Wilson SH, and Goodman MF. Abasic translesion synthesis by DNA polymerase beta violates the "A-rule". Novel types of nucleotide incorporation by human DNA polymerase beta at an abasic lesion in different sequence contexts. J Biol Chem 272: 2559-2569, 1997.
74. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, and Naka-mura Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 52: 5368-5372, 1992.
75. Esposito G, Godindagger I, Klein U, Yaspo ML, Cumano A, and Rajewsky K. Disruption of the Rev3l-encoded catalytic subunit of polymerase zeta in mice results in early embryonic lethality. Curr Biol 10: 1221-1224, 2000.
76. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, and Ashworth A. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921, 2005.
77. Flanagan AM, Rafferty G, O'Neill A, Rynne L, Kelly J, McCann J, and Carty MP. The human POLH gene is not mutated, and is expressed in a cohort of patients with basal or squamous cell carcinoma of the skin. Int J Mol Med 19: 589-596, 2007.
78. Fortini P and Dogliotti E. Base damage and single-strand break repair: mechanisms and functional significance of short-and long-patch repair subpathways. DNA Repair (Amst) 6: 398-409, 2007.
79. Frank EG and Woodgate R. Increased catalytic activity and altered fidelity of human DNA polymerase iota in the presence of manganese. J Biol Chem 282: 24689-24696, 2007.
80. Frechet M, Canitrot Y, Bieth A, Dogliotti E, Cazaux C, and Hoffmann JS. Deregulated DNA polymerase beta strengthens ionizing radiation-induced nucleotidic and chromosomal instabilities. Oncogene 21: 2320-2327, 2002.
81. Friedberg EC. Suffering in silence: the tolerance of DNA damage. Nat Rev Mol Cell Biol 6: 943-953, 2005.
82. Fromme JC, Banerjee A, and Verdine GL. DNA glycosylase recognition and catalysis. Curr Opin Struct Biol 14: 43-49, 2004.
83. Fu Y, Zhu Y, Zhang K, Yeung M, Durocher D, and Xiao W. Rad6-Rad18 mediates a eukaryotic SOS response by ubi-quitinating the 9-1-1 checkpoint clamp. Cell 133: 601-611, 2008.
84. Gao Z, Maloney DJ, Dedkova LM, and Hecht SM. Inhibitors of DNA polymerase beta: activity and mechanism. Bioorg Med Chem 16: 4331-4340, 2008.
85. Garcia-Diaz M, Bebenek K, Krahn JM, Kunkel TA, and Pedersen LC. A closed conformation for the Pol lambda catalytic cycle. Nat Struct Mol Biol 12: 97-98, 2005.
86. Garcia-Diaz M, Dominguez O, Lopez-Fernandez LA, de Lera LT, Saniger ML, Ruiz JF, Parraga M, Garcia-Ortiz MJ, Kirchhoff T, del Mazo J, Bernad A, and Blanco L. DNA polymerase lambda (Pol lambda), a novel eukaryotic DNA polymerase with a potential role in meiosis. J Mol Biol 301: 851-867, 2000.
87. Glick E, White LM, Elliott NA, Berg D, Kiviat NB, and Loeb LA. Mutations in DNA polymerase eta are not detected in squamous cell carcinoma of the skin. Int J Cancer 119: 2225-2227, 2006.
88. Goellner EM, Svilar D, Almeida KH, and Sobol RW. Targeting DNA polymerase ss for therapeutic intervention. Curr Mol Pharmacol 5: 68-87, 2012.
89. Goff JP, Shields DS, Seki M, Choi S, Epperly MW, Dixon T, Wang H, Bakkenist CJ, Dertinger SD, Torous DK, Witt-schieben J, Wood RD, and Greenberger JS. Lack of DNA polymerase theta (POLQ) radiosensitizes bone marrow stromal cells in vitro and increases reticulocyte micronuclei after total-body irradiation. Radiat Res 172: 165-174, 2009.
90. Goodhead DT. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol 65: 7-17, 1994.
91. Goodman MF. Error-prone repair DNA polymerases in prokaryotes and eukaryotes. Annu Rev Biochem 71: 17-50, 2002.
92. Goodman MF and Tippin B. The expanding polymerase universe. Nat Rev Mol Cell Biol 1: 101-109, 2000.
93. Gu H, Marth JD, Orban PC, Mossmann H, and Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265: 103-106, 1994.
94. Gueranger Q, Stary A, Aoufouchi S, Faili A, Sarasin A, Reynaud CA, and Weill JC. Role of DNA polymerases eta, iota and zeta in UV resistance and UV-induced mutagen-esis in a human cell line. DNA Repair (Amst) 7: 1551-1562, 2008.
95. Guo C, Kosarek-Stancel JN, Tang TS, and Friedberg EC. Y-family DNA polymerases in mammalian cells. Cell Mol Life Sci 66: 2363-2381, 2009.
96. Hall MD, Okabe M, Shen DW, Liang XJ, and Gottesman MM. The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol 48: 495-535, 2008.
97. Hara K, Hashimoto H, Murakumo Y, Kobayashi S, Kogame T, Unzai S, Akashi S, Takeda S, Shimizu T, and Sato M. Crystal structure of human REV7 in complex with a human REV3 fragment and structural implication of the interaction between DNA polymerase zeta and REV1. J Biol Chem 285: 12299-12307, 2010.
98. Haracska L, Acharya N, Unk I, Johnson RE, Hurwitz J, Prakash L, and Prakash S. A single domain in human DNA polymerase iota mediates interaction with PCNA: implications for translesion DNA synthesis. Mol Cell Biol 25: 1183-1190, 2005.
99. Haracska L, Prakash L, and Prakash S. Role of human DNA polymerase kappa as an extender in translesion synthesis. Proc Natl Acad Sci USA 99: 16000-16005, 2002.
100. Haracska L, Torres-Ramos CA, Johnson RE, Prakash S, and Prakash L. Opposing effects of ubiquitin conjugation and SUMO modification of PCNA on replicational bypass of DNA lesions in Saccharomyces cerevisiae. Mol Cell Biol 24: 4267-4274, 2004.
101. Havener JM, Nick McElhinny SA, Bassett E, Gauger M, Ramsden DA, and Chaney SG. Translesion synthesis past platinum DNA adducts by human DNA polymerase mu. Biochemistry 42: 1777-1788, 2003.
102. Helleday T, Petermann E, Lundin C, Hodgson B, and Sharma RA. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 8: 193-204, 2008.
103. Hibbert RG, Huang A, Boelens R, and Sixma TK. E3 ligase Rad18 promotes monoubiquitination rather than ubiquitin chain formation byE2 enzyme Rad6. Proc Natl Acad Sci USA 108: 5590-5595, 2011.
104. Higgins GS, Harris AL, Prevo R, Helleday T, McKenna WG, and Buffa FM. Overexpression of POLQ confers a poor prognosis in early breast cancer patients. Oncotarget 1: 175-184, 2010.
105. Higgins GS, Prevo R, Lee YF, Helleday T, Muschel RJ, Taylor S, Yoshimura M, Hickson ID, Bernhard EJ, and McKenna WG. A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radio-sensitization by POLQ knockdown. Cancer Res 70: 2984-2993, 2010.
106. Hirose F, Hotta Y, Yamaguchi M, and Matsukage A. Difference in the expression level of DNA polymerase beta among mouse tissues: high expression in the pachytene spermatocyte. Exp Cell Res 181: 169-180, 1989.
107. Hogg M, Seki M, Wood RD, Doublie S, and Wallace SS. Lesion bypass activity of DNA polymerase theta (POLQ) is an intrinsic property of the pol domain and depends on unique sequence inserts. J Mol Biol 405: 642-652, 2011.
108. Horton JK, Baker A, Berg BJ, Sobol RW, and Wilson SH. Involvement of DNA polymerase beta in protection against the cytotoxicity of oxidative DNA damage. DNA Repair (Amst) 1: 317-333, 2002.
109. Hubscher U, Maga G, and Spadari S. Eukaryotic DNA polymerases. Annu Rev Biochem 71: 133-163, 2002.
110. Inui H, Oh KS, Nadem C, Ueda T, Khan SG, Metin A, Gozukara E, Emmert S, Slor H, Busch DB, Baker CC, Di-Giovanna JJ, Tamura D, Seitz CS, Gratchev A, Wu WH, Chung KY, Chung HJ, Azizi E, Woodgate R, Schneider TD, and Kraemer KH. Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J Invest Dermatol 128: 2055-2068, 2008.
111. Ishimaru C, Kuriyama I, Shimazaki N, Koiwai O, Sakaguchi K, Kato I, Yoshida H, and Mizushina Y. Cholesterol hemisuccinate: a selective inhibitor of family X DNA polymerases. Biochem Biophys Res Commun 354: 619-625, 2007.
112. Ito A, Koshikawa N, Mochizuki S, Omura K, and Takenaga K. Hypoxia-inducible factor-1 mediates the expression of DNA polymerase iota in human tumor cells. Biochem Bio-phys Res Commun 351: 306-311, 2006.
113. Jaiswal AS, Banerjee S, Aneja R, Sarkar FH, Ostrov DA, and Narayan S. DNA polymerase beta as a novel target for chemotherapeutic intervention of colorectal cancer. PLoS One 6: e16691, 2011.
114. Johansson E and Macneill SA. The eukaryotic replicative DNA polymerases take shape. Trends Biochem Sci 35: 339-347, 2010.
115. Johnson KA. The kinetic and chemical mechanism of high-fidelity DNA polymerases. Biochim Biophys Acta 1804: 1041-1048, 2010.
116. Johnson RE, Haracska L, Prakash L, and Prakash S. Role of hoogsteen edge hydrogen bonding at template purines in nucleotide incorporation by human DNA polymerase iota. Mol Cell Biol 26: 6435-6441, 2006.
117. Johnson RE, Kondratick CM, Prakash S, and Prakash L. hRAD30 mutations in the variant form of xeroderma pig-mentosum. Science 285: 263-265, 1999.
118. Johnson RE, Washington MT, Haracska L, Prakash S, and Prakash L. Eukaryotic polymerases iota and zeta act sequentially to bypass DNA lesions. Nature 406: 1015-1019, 2000.
119. Johnson RE, Yu SL, Prakash S, and Prakash L. A role for yeast and human translesion synthesis DNA polymerases in promoting replication through 3-methyl adenine. Mol Cell Biol 27: 7198-7205, 2007.
120. Kai M and Wang TS. Checkpoint responses to replication stalling: inducing tolerance and preventing mutagenesis. Mutat Res 532: 59-73, 2003.
121. Kakar S, Watson NB, and McGregor WG. RAD18 signals DNA polymerase IOTA to stalled replication forks in cells entering S-phase with DNA damage. Adv Exp Med Biol 614: 137-143, 2008.
122. Kamisuki S, Ishimaru C, Onoda K, Kuriyama I, Ida N, Sugawara F, Yoshida H, and Mizushina Y. Nodulisporol and Nodulisporone, novel specific inhibitors of human DNA polymerase lambda from a fungus, Nodulisporium sp. Bioorg Med Chem 15: 3109-3114, 2007.
123. Kannouche P, Broughton BC, Volker M, Hanaoka F, Mul-lenders LH, and Lehmann AR. Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. Genes Dev 15: 158-172, 2001.
124. Kannouche P, Fernandez de Henestrosa AR, Coull B, Vidal AE, Gray C, Zicha D, Woodgate R, and Lehmann AR. Localization of DNA polymerases eta and iota to the replication machinery is tightly co-ordinated in human cells. EMBO J 22: 1223-1233, 2003.
125. Kannouche P and Stary A. Xeroderma pigmentosum variant and error-prone DNA polymerases. Biochimie 85: 1123-1132, 2003.
126. Kawamoto T, Araki K, Sonoda E, Yamashita YM, Harada K, Kikuchi K, Masutani C, Hanaoka F, Nozaki K, Hashimoto N, and Takeda S. Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis. Mol Cell 20: 793-799, 2005.
127. Kawamura K, Bahar R, Seimiya M, Chiyo M, Wada A, Okada S, Hatano M, Tokuhisa T, Kimura H, Watanabe S, Honda I, Sakiyama S, Tagawa M, and O-Wang J. DNA polymerase theta is preferentially expressed in lymphoid tissues and upregulated in human cancers. Int J Cancer 109: 9-16, 2004.
128. Kimura T, Nishida M, Kuramochi K, Sugawara F, Yoshida H, and Mizushina Y. Novel azaphilones, kasanosins A and B, which are specific inhibitors of eukaryotic DNA poly-merases beta and lambda from Talaromyces sp. Bioorg Med Chem 16: 4594-4599, 2008.
129. Kimura T, Takeuchi T, Kumamoto-Yonezawa Y, Ohashi E, Ohmori H, Masutani C, Hanaoka F, Sugawara F, Yoshida H, and Mizushina Y. Penicilliols A and B, novel inhibitors specific to mammalian Y-family DNA polymerases. Bioorg Med Chem 17: 1811-1816, 2009.
130. King NM, Nikolaishvili-Feinberg N, Bryant MF, Luche DD, Heffernan TP, Simpson DA, Hanaoka F, Kaufmann WK, and Cordeiro-Stone M. Overproduction of DNA polymer-ase eta does not raise the spontaneous mutation rate in diploid human fibroblasts. DNA Repair (Amst) 4: 714-724, 2005.
131. Klungland A and Lindahl T. Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1). EMBO J 16: 3341-3348, 1997.
132. Kobayashi S, Valentine MR, Pham P, O'Donnell M, and Goodman MF. Fidelity of Escherichia coli DNA polymerase IV. Preferential generation of small deletion mutations by dNTP-stabilized misalignment. J Biol Chem 277: 34198-34207, 2002.
133. Kohzaki M, Nishihara K, Hirota K, Sonoda E, Yoshimura M, Ekino S, Butler JE, Watanabe M, Halazonetis TD, and Takeda S. DNA polymerases nu and theta are required for efficient immunoglobulin V gene diversification in chicken. J Cell Biol 189: 1117-1127, 2010.
134. Kunkel TA. Considering the cancer consequences of altered DNA polymerase function. Cancer Cell 3: 105-110, 2003.
135. Kunkel TA and Bebenek K. DNA replication fidelity. Annu Rev Biochem 69: 497-529, 2000.
136. Kunkel TA and Burgers PM. Dividing the workload at a eukaryotic replication fork. Trends Cell Biol 18: 521-527, 2008.
137. Kusumoto R, Masutani C, Shimmyo S, Iwai S, and Ha-naoka F. DNA binding properties of human DNA poly-merase eta: implications for fidelity and polymerase switching of translesion synthesis. Genes Cells 9: 1139-1150, 2004.
138. Lang T, Dalal S, Chikova A, DiMaio D, and Sweasy JB. The E295K DNA polymerase beta gastric cancer-associated variant interferes with base excision repair and induces cellular transformation. Mol Cell Biol 27: 5587-5596, 2007.
139. Lang T, Maitra M, Starcevic D, Li SX, and Sweasy JB. A DNA polymerase beta mutant from colon cancer cells induces mutations. Proc Natl Acad Sci USA 101: 6074-6079, 2004.
140. Lange SS, Takata K, and Wood RD. DNA polymerases and cancer. Nat Rev Cancer 11: 96-110, 2011.
141. Lawson MH, Cummings NM, Rassl DM, Russell R, Bren-ton JD, Rintoul RC, and Murphy G. Two novel determinants of etoposide resistance in small cell lung cancer. Cancer Res 71: 4877-4887, 2011.
142. Lee GH and Matsushita H. Genetic linkage between Pol iota deficiency and increased susceptibility to lung tumors in mice. Cancer Sci 96: 256-259, 2005.
143. Lee JW, Blanco L, Zhou T, Garcia-Diaz M, Bebenek K, Kunkel TA, Wang Z, and Povirk LF. Implication of DNA polymerase lambda in alignment-based gap filling for nonhomologous DNA end joining in human nuclear extracts. J Biol Chem 279: 805-811, 2004.
144. Lehmann AR, Niimi A, Ogi T, Brown S, Sabbioneda S, Wing JF, Kannouche PL, and Green CM. Translesion synthesis: Y-family polymerases and the polymerase switch. DNA Repair (Amst) 6: 891-899, 2007.
145. Lemee F, Bergoglio V, Fernandez-Vidal A, Machado-Silva A, Pillaire MJ, Bieth A, Gentil C, Baker L, Martin AL, Leduc C, Lam E, Magdeleine E, Filleron T, Oumouhou N, Kaina B, Seki M, Grimal F, Lacroix-Triki M, Thompson A, Roche H, Bourdon JC, Wood RD, Hoffmann JS, and Cazaux C. DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability. Proc Natl Acad Sci USA 107: 13390-13395, 2010.
146. Li SS, Gao Z, Feng X, Jones SH, and Hecht SM. Plant sterols as selective DNA polymerase beta lyase inhibitors and potentiators of bleomycin cytotoxicity. Bioorg Med Chem 12: 4253-4258, 2004.
147. Lichon V and Khachemoune A. Xeroderma pigmentosum: beyond skin cancer. J Drugs Dermatol 6: 281-288, 2007.
148. Lin X, Trang J, Okuda T, and Howell SB. DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair. Clin Cancer Res 12: 563-568, 2006.
149. Lindahl T and Wood RD. Quality control by DNA repair. Science 286: 1897-1905, 1999.
150. Ling H, Boudsocq F, Woodgate R, and Yang W. Crystal structure of a Y-family DNA polymerase in action: a mechanism for error-prone and lesion-bypass replication. Cell 107: 91-102, 2001.
151. Loh SY, Mistry P, Kelland LR, Abel G, and Harrap KR. Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes. Br J Cancer 66: 1109-1115, 1992.
152. Lone S, Townson SA, Uljon SN, Johnson RE, Brahma A, Nair DT, Prakash S, Prakash L, and Aggarwal AK. Human DNA polymerase kappa encircles DNA: implications for mismatch extension and lesion bypass. Mol Cell 25: 601-614, 2007.
153. Lucas D, Escudero B, Ligos JM, Segovia JC, Estrada JC, Terrados G, Blanco L, Samper E, and Bernad A. Altered hematopoiesis in mice lacking DNA polymerase mu is due to inefficient double-strand break repair. PLoS Genet 5: e1000389, 2009.
154. Ma Y, Lu H, Tippin B, Goodman MF, Shimazaki N, Koiwai O, Hsieh CL, Schwarz K, and Lieber MR. A biochemically defined system for mammalian nonhomologous DNA end joining. Mol Cell 16: 701-713, 2004.
155. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, and Pontes JE. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 54: 3824-3830, 1994.
156. Maga G, Villani G, Crespan E, Wimmer U, Ferrari E, Ber-tocci B, and Hubscher U. 8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins. Nature 447: 606-608, 2007.
157. Mahajan KN, Nick McElhinny SA, Mitchell BS, and Ramsden DA. Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for pol mu in end-joining double-strand break repair. Mol Cell Biol 22: 5194-5202, 2002.
158. Mahaney BL, Meek K, and Lees-Miller SP. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J 417: 639-650, 2009.
159. Maitra M, Gudzelak A, Jr., Li SX, Matsumoto Y, Eckert KA, Jager J, and Sweasy JB. Threonine 79 is a hinge residue that governs the fidelity of DNA polymerase beta by helping to position the DNA within the active site. J Biol Chem 277: 35550-35560, 2002.
160. Martomo SA, Saribasak H, Yokoi M, Hanaoka F, and Gearhart PJ. Reevaluation of the role of DNA polymerase theta in somatic hypermutation of immunoglobulin genes. DNA Repair (Amst) 7: 1603-1608, 2008.
161. Masutani C, Kusumoto R, Iwai S, and Hanaoka F. Mechanisms of accurate translesion synthesis by human DNA polymerase eta. EMBO J 19: 3100-3109, 2000.
162. Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, Araki M, Iwai S, Takio K, and Hanaoka F. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399: 700-704, 1999.
163. Matsukage A, Yamaguchi M, Utsumi KR, Hayashi Y, Ueda R, and Yoshida MC. Assignment of the gene for human DNA polymerase beta (POLB) to chromosome 8. Jpn J Cancer Res 77: 330-333, 1986.
164. Matsumoto Y and Kim K. Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science 269: 699-702, 1995.
165. McCulloch SD, Kokoska RJ, Chilkova O, Welch CM, Johansson E, Burgers PM, and Kunkel TA. Enzymatic switching for efficient and accurate translesion DNA replication. Nucleic Acids Res 32: 4665-4675, 2004.
166. McCulloch SD, Kokoska RJ, Masutani C, Iwai S, Hanaoka F, and Kunkel TA. Preferential cis-syn thymine dimer bypass by DNA polymerase eta occurs with biased fidelity. Nature 428: 97-100, 2004.
167. McCulloch SD and Kunkel TA. The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res 18: 148-161, 2008.
168. McCullough AK, Dodson ML, and Lloyd RS. Initiation of base excision repair: glycosylase mechanisms and structures. Annu Rev Biochem 68: 255-285, 1999.
169. McDonald JP, Tissier A, Frank EG, Iwai S, Hanaoka F, and Woodgate R. DNA polymerase iota and related rad30-like enzymes. Philos Trans R Soc Lond B Biol Sci 356: 53-60, 2001.
170. McIlwraith MJ, Vaisman A, Liu Y, Fanning E, Woodgate R, and West SC. Human DNA polymerase eta promotes DNA synthesis from strand invasion intermediates of homologous recombination. Mol Cell 20: 783-792, 2005.
171. Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, and de Vries EG. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Cancer Res 52: 6885-6889, 1992.
172. Mellish KJ, Kelland LR, and Harrap KR. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Br J Cancer 68: 240-250, 1993.
173. Michel B, Grompone G, Flores MJ, and Bidnenko V. Multiple pathways process stalled replication forks. Proc Natl Acad Sci USA 101: 12783-12788, 2004.
174. Minko IG, Harbut MB, Kozekov ID, Kozekova A, Jakobs PM, Olson SB, Moses RE, Harris TM, Rizzo CJ, and Lloyd RS. Role for DNA polymerase kappa in the processing of N2-N2-guanine interstrand cross-links. J Biol Chem 283: 17075-17082, 2008.
175. Mizushina Y, Motoshima H, Yamaguchi Y, Takeuchi T, Hirano K, Sugawara F, and Yoshida H. 3-O-methylfuni-cone, a selective inhibitor of mammalian Y-family DNA polymerases from an Australian sea salt fungal strain. Mar Drugs 7: 624-639, 2009.
176. Mizushina Y, Nakagawa K, Shibata A, Awata Y, Kuriyama I, Shimazaki N, Koiwai O, Uchiyama Y, Sakaguchi K, Miyazawa T, and Yoshida H. Inhibitory effect of tocotrienol on eukaryotic DNA polymerase lambda and angiogenesis. Biochem Biophys Res Commun 339: 949-955, 2006.
177. Moon AF, Garcia-Diaz M, Batra VK, Beard WA, Bebenek K, Kunkel TA, Wilson SH, and Pedersen LC. The X family portrait: structural insights into biological functions of X family polymerases. DNA Repair (Amst) 6: 1709-1725, 2007.
178. Mueller GA, Moon AF, Derose EF, Havener JM, Ramsden DA, Pedersen LC, and London RE. A comparison of BRCT domains involved in nonhomologous end-joining: introducing the solution structure of the BRCT domain of polymerase lambda. DNA Repair (Amst) 7: 1340-1351, 2008.
179. Muzzini DM, Plevani P, Boulton SJ, Cassata G, and Marini F. Caenorhabditis elegans POLQ-1 and HEL-308 function in two distinct DNA interstrand cross-link repair pathways. DNA Repair (Amst) 7: 941-950, 2008.
180. Naganuma M, Nishida M, Kuramochi K, Sugawara F, Yoshida H, and Mizushina Y. 1-deoxyrubralactone, a novel specific inhibitor of families X and Y of eukaryotic DNA polymerases from a fungal strain derived from sea algae. Bioorg Med Chem 16: 2939-2944, 2008.
181. Nair DT, Johnson RE, Prakash S, Prakash L, and Aggarwal AK. Replication by human DNA polymerase-iota occurs by Hoogsteen base-pairing. Nature 430: 377-380, 2004.
182. Neijenhuis S, Begg AC, and Vens C. Radiosensitization by a dominant negative to DNA polymerase beta is DNA polymerase beta-independent and XRCC1-dependent. Radiother Oncol 76: 123-128, 2005.
183. Neijenhuis S, Verwijs-Janssen M, Kasten-Pisula U, Rump-ing G, Borgmann K, Dikomey E, Begg AC, and Vens C. Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase beta. DNA Repair (Amst) 8: 336-346, 2009.
184. Nick McElhinny SA and Ramsden DA. Polymerase mu is a DNA-directed DNA/RNA polymerase. Mol Cell Biol 23: 2309-2315, 2003.
185. O-Wang J, Kawamura K, Tada Y, Ohmori H, Kimura H, Sakiyama S, and Tagawa M. DNA polymerase kappa, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer. Cancer Res 61: 5366-5369, 2001.
186. Ochs K, Sobol RW, Wilson SH, and Kaina B. Cells deficient in DNA polymerase beta are hypersensitive to alkylating agent-induced apoptosis and chromosomal breakage. Cancer Res 59: 1544-1551, 1999.
187. Ogi T, Kannouche P, and Lehmann AR. Localisation of human Y-family DNA polymerase kappa: relationship to PCNA foci. J Cell Sci 118: 129-136, 2005.
188. Ogi T and Lehmann AR. The Y-family DNA polymerase kappa (pol kappa) functions in mammalian nucleotide-ex-cision repair. Nat Cell Biol 8: 640-642, 2006.
189. Ogi T, Limsirichaikul S, Overmeer RM, Volker M, Take-naka K, Cloney R, Nakazawa Y, Niimi A, Miki Y, Jaspers NG, Mullenders LH, Yamashita S, Fousteri MI, and Lehmann AR. Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells. Mol Cell 37: 714-727, 2010.
190. Ohashi E, Bebenek K, Matsuda T, Feaver WJ, Gerlach VL, Friedberg EC, Ohmori H, and Kunkel TA. Fidelity and processivity of DNA synthesis by DNA polymerase kappa, the product of the human DINB1 gene. J Biol Chem 275: 39678-39684, 2000.
191. Ohashi E, Hanafusa T, Kamei K, Song I, Tomida J, Hashimoto H, Vaziri C, and Ohmori H. Identification of a novel REV1-interacting motif necessary for DNA poly-merase kappa function. Genes Cells 14: 101-111, 2009.
192. Ohba T, Kometani T, Shoji F, Yano T, Yoshino I, Taguchi K, Kuraoka I, Oda S, and Maehara Y. Expression of an X-family DNA polymerase, pol lambda, in the respiratory epithelium of non-small cell lung cancer patients with habitual smoking. Mutat Res 677: 66-71, 2009.
193. Ohkumo T, Kondo Y, Yokoi M, Tsukamoto T, Yamada A, Sugimoto T, Kanao R, Higashi Y, Kondoh H, Tatematsu M, Masutani C, and Hanaoka F. UV-B radiation induces epithelial tumors in mice lacking DNA polymerase eta and mesenchymal tumors in mice deficient for DNA polymer-ase iota. Mol Cell Biol 26: 7696-7706, 2006.
194. Pan Q, Fang Y, Xu Y, Zhang K, and Hu X. Down-regulation of DNA polymerases kappa, eta, iota, and zeta in human lung, stomach, and colorectal cancers. Cancer Lett 217: 139-147, 2005.
195. Parsons JL, Dianova, II, Allinson SL, and Dianov GL. DNA polymerase beta promotes recruitment of DNA ligase III alpha-XRCC1 to sites of base excision repair. Biochemistry 44: 10613-10619, 2005.
196. Pascucci B, Stucki M, Jonsson ZO, Dogliotti E, and Hub-scher U. Long patch base excision repair with purified human proteins. DNA ligase I as patch size mediator for DNA polymerases delta and epsilon. J Biol Chem 274: 33696-33702, 1999.
197. Pelletier H, Sawaya MR, Kumar A, Wilson SH, and Kraut J. Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP. Science 264: 1891-1903, 1994.
198. Petta TB, Nakajima S, Zlatanou A, Despras E, Couve-Privat S, Ishchenko A, Sarasin A, Yasui A, and Kannouche P. Human DNA polymerase iota protects cells against oxi-dative stress. EMBO J 27: 2883-2895, 2008.
199. Pillaire MJ, Betous R, Conti C, Czaplicki J, Pasero P, Ben-simon A, Cazaux C, and Hoffmann JS. Upregulation of error-prone DNA polymerases beta and kappa slows down fork progression without activating the replication checkpoint. Cell Cycle 6: 471-477, 2007.
200. Pillaire MJ, Selves J, Gordien K, Gourraud PA, Gentil C, Danjoux M, Do C, Negre V, Bieth A, Guimbaud R, Trouche D, Pasero P, Mechali M, Hoffmann JS, and Cazaux C. A 'DNA replication' signature of progression and negative outcome in colorectal cancer. Oncogene 29: 876-887, 2010.
201. Poltoratsky V, Horton JK, Prasad R, Beard WA, Woodgate R, and Wilson SH. Negligible impact of pol iota expression on the alkylation sensitivity of pol beta-deficient mouse fibroblast cells. DNA Repair (Amst) 7: 830-833, 2008.
202. Poltoratsky V, Horton JK, Prasad R, and Wilson SH. REV1 mediated mutagenesis in base excision repair deficient mouse fibroblast. DNA Repair (Amst) 4: 1182-1188, 2005.
203. Prakash S, Johnson RE, and Prakash L. Eukaryotic trans-lesion synthesis DNA polymerases: specificity of structure and function. Annu Rev Biochem 74: 317-353, 2005.
204. Prakasha Gowda AS, Polizzi JM, Eckert KA, and Spratt TE. Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1. Biochemistry 49: 4833-4840, 2010.
205. Prasad R, Beard WA, Strauss PR, and Wilson SH. Human DNA polymerase beta deoxyribose phosphate lyase. Substrate specificity and catalytic mechanism. J Biol Chem 273: 15263-15270, 1998.
206. Prasad R, Longley MJ, Sharief FS, Hou EW, Copeland WC, and Wilson SH. Human DNA polymerase theta possesses 5¢-dRP lyase activity and functions in single-nucleotide base excision repair in vitro. Nucleic Acids Res 37: 1868-1877, 2009.
207. Prasad R, Widen SG, Singhal RK, Watkins J, Prakash L, and Wilson SH. Yeast open reading frame YCR14C encodes a DNA beta-polymerase-like enzyme. Nucleic Acids Res 21: 5301-5307, 1993.
208. Preston BD, Albertson TM, and Herr AJ. DNA replication fidelity and cancer. Semin Cancer Biol 20: 281-293, 2010.
209. Rajpal DK, Wu X, and Wang Z. Alteration of ultraviolet-induced mutagenesis in yeast through molecular modulation of the REV3 and REV7 gene expression. Mutat Res 461: 133-143, 2000.
210. Rechkoblit O, Zhang Y, Guo D, Wang Z, Amin S, Krze-minsky J, Louneva N, and Geacintov NE. trans-Lesion synthesis past bulky benzo[a]pyrene diol epoxide N2-dG and N6-dA lesions catalyzed by DNA bypass polymerases. J Biol Chem 277: 30488-30494, 2002.
211. Roettger MP, Fiala KA, Sompalli S, Dong Y, and Suo Z. Pre-steady-state kinetic studies of the fidelity of human DNA polymerase mu. Biochemistry 43: 13827-13838, 2004.
212. Ruiz JF, Juarez R, Garcia-Diaz M, Terrados G, Picher AJ, Gonzalez-Barrera S, Fernandez de Henestrosa AR, and Blanco L. Lack of sugar discrimination by human Pol mu requires a single glycine residue. Nucleic Acids Res 31: 4441-4449, 2003.
213. Ruiz JF, Lucas D, Garcia-Palomero E, Saez AI, Gonzalez MA, Piris MA, Bernad A, and Blanco L. Overexpression of human DNA polymerase mu (Pol mu) in a Burkitt's lym-phoma cell line affects the somatic hypermutation rate. Nucleic Acids Res 32: 5861-5873, 2004.
214. Sabbioneda S, Minesinger BK, Giannattasio M, Plevani P, Muzi-Falconi M, and Jinks-Robertson S. The 9-1-1 checkpoint clamp physically interacts with polzeta and is partially required for spontaneous polzeta-dependent mu-tagenesis in Saccharomyces cerevisiae. J Biol Chem 280: 38657-38665, 2005.
215. Sanderson RJ and Mosbaugh DW. Fidelity and mutational specificity of uracil-initiated base excision DNA repair synthesis in human glioblastoma cell extracts. J Biol Chem 273: 24822-24831, 1998.
216. Schmutz V, Janel-Bintz R, Wagner J, Biard D, Shiomi N, Fuchs RP, and Cordonnier AM. Role of the ubiquitin-binding domain of Poleta in Rad18-independent transle-sion DNA synthesis in human cell extracts. Nucleic Acids Res 38: 6456-6465, 2010.
217. Seki M, Marini F, and Wood RD. POLQ (Pol theta), a DNA polymerase and DNA-dependent ATPase in human cells. Nucleic Acids Res 31: 6117-6126, 2003.
218. Seki M, Masutani C, Yang LW, Schuffert A, Iwai S, Bahar I, and Wood RD. High-efficiency bypass of DNA damage by human DNA polymerase Q. EMBO J 23: 4484-4494, 2004.
219. Seki M and Wood RD. DNA polymerase theta (POLQ) can extend from mismatches and from bases opposite a (6-4) photoproduct. DNA Repair (Amst) 7: 119-127, 2008.
220. Servant L, Cazaux C, Bieth A, Iwai S, Hanaoka F, and Hoffmann JS. A role for DNA polymerase beta in muta-genic UV lesion bypass. J Biol Chem 277: 50046-50053, 2002.
221. Sharma RA and Dianov GL. Targeting base excision repair to improve cancer therapies. Mol Aspects Med 28: 345-374, 2007.
222. Shevelev IV and Hubscher U. The 3¢ 5¢ exonucleases. Nat Rev Mol Cell Biol 3: 364-376, 2002.
223. Shimizu T, Azuma T, Ishiguro M, Kanjo N, Yamada S, and Ohmori H. Normal immunoglobulin gene somatic hy-permutation in Pol kappa-Pol iota double-deficient mice. Immunol Lett 98: 259-264, 2005.
224. Silverstein TD, Johnson RE, Jain R, Prakash L, Prakash S, and Aggarwal AK. Structural basis for the suppression of skin cancers by DNA polymerase eta. Nature 465: 1039-1043, 2010.
225. Sleeth KM, Robson RL, and Dianov GL. Exchangeability of mammalian DNA ligases between base excision repair pathways. Biochemistry 43: 12924-12930, 2004.
226. Sobol RW, Horton JK, Kuhn R, Gu H, Singhal RK, Prasad R, Rajewsky K, and Wilson SH. Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature 379: 183-186, 1996.
227. Sobol RW, Watson DE, Nakamura J, Yakes FM, Hou E, Horton JK, Ladapo J, Van Houten B, Swenberg JA, Tindall KR, Samson LD, and Wilson SH. Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress. Proc Natl Acad Sci USA 99: 6860-6865, 2002.
228. Srivastava DK, Husain I, Arteaga CL, and Wilson SH. DNA polymerase beta expression differences in selected human tumors and cell lines. Carcinogenesis 20: 1049-1054, 1999.
229. Stachelek GC, Dalal S, Donigan KA, Campisi Hegan D, Sweasy JB, and Glazer PM. Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation. Cancer Res 70: 409-417, 2010.
230. Stancel JN, McDaniel LD, Velasco S, Richardson J, Guo C, and Friedberg EC. Polk mutant mice have a spontaneous mutator phenotype. DNA Repair (Amst) 8: 1355-1362, 2009.
231. Starcevic D, Dalal S, and Sweasy JB. Is there a link between DNA polymerase beta and cancer? Cell Cycle 3: 998-1001, 2004.
232. Steitz TA. DNA polymerases: structural diversity and common mechanisms. J Biol Chem 274: 17395-17398, 1999.
233. Sukhanova MV, Khodyreva SN, Lebedeva NA, Prasad R, Wilson SH, and Lavrik OI. Human base excision repair enzymes apurinic/apyrimidinic endonuclease1 (APE1), DNA polymerase beta and poly(ADP-ribose) polymerase 1: interplay between strand-displacement DNA synthesis and proofreading exonuclease activity. Nucleic Acids Res 33: 1222-1229, 2005.
234. Sweasy JB, Lang T, Starcevic D, Sun KW, Lai CC, Dimaio D, and Dalal S. Expression of DNA polymerase {beta} cancer-associated variants in mouse cells results in cellular transformation. Proc Natl Acad Sci USA 102: 14350-14355, 2005.
235. Takenaka K, Ogi T, Okada T, Sonoda E, Guo C, Friedberg EC, and Takeda S. Involvement of vertebrate Polkappa in translesion DNA synthesis across DNA monoalkylation damage. J Biol Chem 281: 2000-2004, 2006.
236. Tanioka M, Masaki T, Ono R, Nagano T, Otoshi-Honda E, Matsumura Y, Takigawa M, Inui H, Miyachi Y, Moriwaki S, and Nishigori C. Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type. J Invest Dermatol 127: 1745-1751, 2007.
237. Teng KY, Qiu MZ, Li ZH, Luo HY, Zeng ZL, Luo RZ, Zhang HZ, Wang ZQ, Li YH, and Xu RH. DNA polymer-ase eta protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy. J Transl Med 8: 126, 2010.
238. Terrados G, Capp JP, Canitrot Y, Garcia-Diaz M, Bebenek K, Kirchhoff T, Villanueva A, Boudsocq F, Bergoglio V, Cazaux C, Kunkel TA, Hoffmann JS, and Blanco L. Characterization of a natural mutator variant of human DNA polymerase lambda which promotes chromosomal instability by compromising NHEJ. PLoS One 4: e7290, 2009.
239. Thakur M, Wernick M, Collins C, Limoli CL, Crowley E, and Cleaver JE. DNA polymerase eta undergoes alternative splicing, protects against UV sensitivity and apoptosis, and suppresses Mre11-dependent recombination. Genes Chromosomes Cancer 32: 222-235, 2001.
240. Trivedi RN, Almeida KH, Fornsaglio JL, Schamus S, and Sobol RW. The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death. Cancer Res 65: 6394-6400, 2005.
241. Trivedi RN, Wang XH, Jelezcova E, Goellner EM, Tang JB, and Sobol RW. Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide. Mol Pharmacol 74: 505-516, 2008.
242. Uchiyama Y, Takeuchi R, Kodera H, and Sakaguchi K. Distribution and roles of X-family DNA polymerases in eukaryotes. Biochimie 91: 165-170, 2009.
243. Vaisman A and Chaney SG. The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta. J Biol Chem 275: 13017-13025, 2000.
244. Vaisman A, Masutani C, Hanaoka F, and Chaney SG. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta. Biochemistry 39: 4575-4580, 2000.
245. Vaisman A, Warren MW, and Chaney SG. The effect of DNA structure on the catalytic efficiency and fidelity of human DNA polymerase beta on templates with platinum-DNA adducts. J Biol Chem 276: 18999-19005, 2001.
246. Valk K, Vooder T, Kolde R, Reintam MA, Petzold C, Vilo J, and Metspalu A. Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers. Oncology 79: 283-292, 2010.
247. van der Bosch K, Becker I, Savelyeva L, Bruderlein S, Schlag P, and Schwab M. Deletions in the short arm of chromosome 8 are present in up to 90% of human colorectal cancer cell lines. Genes Chromosomes Cancer 5: 91-95, 1992.
248. Varadi V, Bevier M, Grzybowska E, Johansson R, Enquist K, Henriksson R, Butkiewicz D, Pamula-Pilat J, Tecza K, Hemminki K, Lenner P, and Forsti A. Genetic variation in genes encoding for polymerase zeta subunits associates with breast cancer risk, tumour characteristics and survival. Breast Cancer Res Treat 129: 235-245, 2011.
249. Vens C, Dahmen-Mooren E, Verwijs-Janssen M, Blyweert W, Graversen L, Bartelink H, and Begg AC. The role of DNA polymerase beta in determining sensitivity to ionizing radiation in human tumor cells. Nucleic Acids Res 30: 2995-3004, 2002.
250. Vermeulen C, Bertocci B, Begg AC, and Vens C. Ionizing radiation sensitivity of DNA polymerase lambda-deficient cells. Radiat Res 168: 683-688, 2007.
251. Wang H, Wu W, Wang HW, Wang S, Chen Y, Zhang X, Yang J, Zhao S, Ding HF, and Lu D. Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance. Neuro Oncol 12: 679-686, 2010.
252. Wang Y, Woodgate R, McManus TP, Mead S, McCormick JJ, and Maher VM. Evidence that in xeroderma pigmento-sum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations. Cancer Res 67: 3018-3026, 2007.
253. Washington MT, Johnson RE, Prakash L, and Prakash S. Accuracy of lesion bypass by yeast and human DNA poly-merase eta. Proc Natl Acad Sci USA 98: 8355-8360, 2001.
254. Washington MT, Johnson RE, Prakash L, and Prakash S. Human DINB1-encoded DNA polymerase kappa is a promiscuous extender of mispaired primer termini. Proc Natl Acad Sci USA 99: 1910-1914, 2002.
255. Watanabe K, Tateishi S, Kawasuji M, Tsurimoto T, Inoue H, and Yamaizumi M. Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J 23: 3886-3896, 2004.
256. Waters LS, Minesinger BK, Wiltrout ME, D'Souza S, Woodruff RV, and Walker GC. Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance. Microbiol Mol Biol Rev 73: 134-154, 2009.
257. Weinfeld M. Complexities of BER. Prog Nucleic Acid Res Mol Biol 68: 125-127, 2001.
258. Wiebauer K and Jiricny J. Mismatch-specific thymine DNA glycosylase and DNA polymerase beta mediate the correction of G.T mispairs in nuclear extracts from human cells. Proc Natl Acad Sci USA 87: 5842-5845, 1990.
259. Wimmer U, Ferrari E, Hunziker P, and Hubscher U. Control of DNA polymerase lambda stability by phosphoryla-tion and ubiquitination during the cell cycle. EMBO Rep 9: 1027-1033, 2008.
260. Wittschieben J, Shivji MK, Lalani E, Jacobs MA, Marini F, Gearhart PJ, Rosewell I, Stamp G, and Wood RD. Disruption of the developmentally regulated Rev3l gene causes embryonic lethality. Curr Biol 10: 1217-1220, 2000.
261. Wittschieben JP, Reshmi SC, Gollin SM, and Wood RD. Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells. Cancer Res 66: 134-142, 2006.
262. Yagi Y, Ogawara D, Iwai S, Hanaoka F, Akiyama M, and Maki H. DNA polymerases eta and kappa are responsible for error-free translesion DNA synthesis activity over a cis-syn thymine dimer in Xenopus laevis oocyte extracts. DNA Repair (Amst) 4: 1252-1269, 2005.
263. Yamtich J, Starcevic D, Lauper J, Smith E, Shi I, Rangarajan S, Jaeger J, and Sweasy JB. Hinge residue I174 is critical for proper dNTP selection by DNA polymerase beta. Biochemistry 49: 2326-2334, 2010.
264. Yamtich J and Sweasy JB. DNA polymerase family X: function, structure, and cellular roles. Biochim Biophys Acta 1804: 1136-1150, 2010.
265. Yang J, Chen Z, Liu Y, Hickey RJ, and Malkas LH. Altered DNA polymerase iota expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis. Cancer Res 64: 5597-5607, 2004.
266. Yang J, Parsons J, Nicolay NH, Caporali S, Harrington CF, Singh R, Finch D, D'Atri S, Farmer PB, Johnston PG, McKenna WG, Dianov G, and Sharma RA. Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy. Oncogene 29: 463-468, 2010.
267. Yasui M, Suzuki N, Laxmi YR, and Shibutani S. Translesion synthesis past tamoxifen-derived DNA adducts by human DNA polymerases eta and kappa. Biochemistry 45: 12167-12174, 2006.
268. Yoshimura M, Kohzaki M, Nakamura J, Asagoshi K, So-noda E, Hou E, Prasad R, Wilson SH, Tano K, Yasui A, Lan L, Seki M, Wood RD, Arakawa H, Buerstedde JM, Ho-chegger H, Okada T, Hiraoka M, and Takeda S. Vertebrate POLQ and POLbeta cooperate in base excision repair of oxidative DNA damage. Mol Cell 24: 115-125, 2006.
269. Zahn KE, Wallace SS, and Doublie S. DNA polymerases provide a canon of strategies for translesion synthesis past oxidatively generated lesions. Curr Opin Struct Biol 21: 358-369, 2011.
270. Zhang Y, Wu X, Guo D, Rechkoblit O, Taylor JS, Geacintov NE, and Wang Z. Lesion bypass activities of human DNA polymerase mu. J Biol Chem 277: 44582-44587, 2002.
271. Zhang Y, Wu X, Yuan F, Xie Z, and Wang Z. Highly frequent frameshift DNA synthesis by human DNA poly-merase mu. Mol Cell Biol 21: 7995-8006, 2001.
272. Zhang Y, Yuan F, Wu X, Rechkoblit O, Taylor JS, Geacintov NE, and Wang Z. Error-prone lesion bypass by human DNA polymerase eta. Nucleic Acids Res 28: 4717-4724, 2000.
273. Zhong X, Garg P, Stith CM, Nick McElhinny SA, Kissling GE, Burgers PM, and Kunkel TA. The fidelity of DNA synthesis by yeast DNA polymerase zeta alone and with accessory proteins. Nucleic Acids Res 34: 4731-4742, 2006.
274. Zmudzka BZ, Fornace A, Collins J, and Wilson SH. Characterization of DNA polymerase beta mRNA: cell-cycle and growth response in cultured human cells. Nucleic Acids Res 16: 9587-9596, 1988.